Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

Combo Treatment Best for Anxiety Disorder in Kids

Zoloft, cognitive behavior therapy also work well alone, study finds

By Steven Reinberg
HealthDay Reporter


Related Encyclopedia
 border=
Acne
Alagille Syndrome
Anxiety
Appendicitis
More...

Related Animations
 border=
Dental Cavities
More...

Related Healthscout Videos
 border=
Picture Perfect Smile
Space Age Dental Scan
Bioengineering versus Avian-Based HA?
Better Balance: It is Rocket Science
More...

Related Drug Information
 border=
Adderal XR
Concerta
Strattera
More...

Related News Articles
 border=
Gender Defines Activity for Kids, Elders
Health Tip: Help Stop Thumbsucking
More 'Screen Time' Linked to Poor Fitness in Girls
Europe Unlikely to Meet Measles Goals: Report
More...

THURSDAY, Oct. 30 (HealthDay News) -- For children with anxiety disorders, a combination of cognitive behavior therapy and the antidepressant sertraline (Zoloft) works better than either treatment alone, researchers report.

However, Zoloft or cognitive behavior therapy by themselves did work in more than half of the patients, according to a report in the Oct. 30 online edition of the New England Journal of Medicine. The report is being published to coincide with a presentation of the findings at the American Academy of Child & Adolescent Psychiatry annual meeting, in Chicago.

Text Continues Below



"For children and adolescents with anxiety disorders, there are three effective treatment choices," said study co-author Anne Marie Albano, an associate professor of clinical psychology at Columbia University in New York City. "What's important about this is families, in consultation with their doctors, can think through which is the best option for them to pursue."

Decisions on treatment can also be made on what's available in the local community, Albano said. "Some communities might not have access to some of these treatments," she said. For example, cognitive behavior therapy requires a specialist in the technique.

Another advantage of having several workable treatments is that treatment decisions can be made on the basis of preference, Albano noted. "Some families don't want to do one treatment versus another. So, families can make a decision based on preference. They might want to make the decision to go with both treatments, because the combination treatment did show an added benefit that the individual therapies don't have," she said.

For the study, Albano's team randomly assigned 488 children aged 7 to 17 with anxiety disorders to 12 weeks of treatment with one of four protocols. Some children were given cognitive behavior therapy, and others were given Zoloft. A third group received both cognitive behavior therapy and Zoloft, while a fourth group received a placebo.

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 10/30/2008

Related Links
 border=
From Healthscout's partner site on anxiety, AnxietyConnection.com
Learn about types of anxiety medication.
What are anxiety treatment options?
Learn to cope with anxiety panic attacks.





SOURCES: Anne Marie Albano, Ph.D., associate professor, clinical psychology, Columbia University, New York City; Jerilyn Ross, president and CEO, Anxiety Disorders Association of America, Silver Spring, Md.; David L. Katz, M.D., M.P.H., director, Prevention Research Center, Yale University Medical School, New Haven, Conn.; Oct. 30, 2008, New England Journal of Medicine, online


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service    

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.